Collins Cooper C. 4
4 · TherapeuticsMD, Inc. · Filed Aug 19, 2021
Insider Transaction Report
Form 4
Collins Cooper C.
Director
Transactions
- Purchase
Common Stock
2021-08-18$0.72/sh+900,000$648,000→ 1,236,864 total - Purchase
Common Stock
2021-08-17$0.77/sh+100,000$77,000→ 336,864 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.746 to $0.78 for an average weighted purchase price of $0.77. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions with prices ranging from $0.715 to $0.727 for an average weighted purchase price of $0.72. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.